Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperlipidemias

• An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
• Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
• Akkermansia Muciniphilia and Metabolic Side Effects of ADT
• "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia
• Cardiovascular Risk Reduction in Epilepsy
• A Study to Assess the Safety and Pharmacokinetics of AD-104-A
• Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects
• Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
• A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
• Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
• Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
• The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia
• A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects
• Evolocumab Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
• Safety and Tolerability of SHR-1918 in Healthy Subjects
• Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
• Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany
• A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia
• A Study of LY3561774 in Participants With Mixed Dyslipidemia
• A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia
• A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia
• A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B
• Effect of Red Yeast Rice Beside Statin on Lipid Profile
• A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia
• Study to Evaluate the Safety and PK of UI018
• A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
• A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia
• Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
• Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia and Hyperlipidemia
• Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage
• The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia
• Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C
• HDDO-1756 Bio Equivalence Study
• Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers
• Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects
• Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects
• Lipid Management in Renal Transplant Recipients Using Evolocumab.
• Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
• Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia
• A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
• To Evaluate the Efficacy and Safety of JS002 in HoFH Patients
• Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia
• Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
• Compare the Pharmacokinetics and Safety of CKD-391
• Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation
• Supplementation of Oil Palm Phenolics to Healthy Participants
• The CHORAL Flow Study
• The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia
• Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
• Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.
• Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
• Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia
• Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
• The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients
• The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
• Effect of Evolocumab on Coronary Artery Plaque Volume and Composition by CCTA and Microcalcification by F18-NaF PET
• Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072
• Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study
• Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012
• Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)
• Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
• Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
• L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
• Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers
• Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
• Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
• Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
• Plasma Lipoprotein Response to Glucagon-like Peptide-2
• Effects of Psyllium on Niacin Tolerability
• Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)
• Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes
• A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
• The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production
• Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin
• Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease
• Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
• Pharmacokinetic Drug-drug Interaction of CKD-330 and D086
• Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.
• Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
• Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
• The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
• A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
• A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin
• Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects
• Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
• Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers
• Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease
• Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia
• Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
• Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
• Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia
• Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
• Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia
• DP-R212 Pharmacokinetic Study
• Orlistat for the Treatment of Type I Hyperlipoproteinemia
• Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))
• Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
• Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects
• Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
• Self-Assessment Method for Statin Side-effects Or Nocebo
• Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia
• A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
• The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome
• A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers
• PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin
• Effect of Rosuvastatin Therapy on HDL2 Level
• Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
• A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet
• Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
• Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
• Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
• Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
• Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
• The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
• Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects
• The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia
• Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
• Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
• The SCCS Polypill Pilot Trial
• Acupuncture and Moxibustion for Hyperlipemia
• Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
• Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
• Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
• Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin
• Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters
• The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
• Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
• Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia
• Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir
• Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
• Efficacy Study of Metformin Glycinate on Postprandial Lipemia
• to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
• CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
• Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002
• Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
• A Pilot Study to Evaluate the Lipid Effects of TRIA-662
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3
• Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
• Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
• Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
• Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk
• The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia
• Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers
• Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg
• Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia
• Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
• Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
• Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia
• Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia
• Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
• Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
• Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
• Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)
• Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia
• A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects
• Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects
• Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2
• LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
• Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2
• The Therapeutic Effects of Statins and Berberine on the Hyperlipemia
• Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
• Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
• Nutraceuticals to Improve Lipid Profile in European Countries
• The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia
• Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
• Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan
• A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes
• Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans
• Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia
• Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
• Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
• Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
• Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol
• Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
• Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study
• Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects
• A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
• Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
• Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
• Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects
• Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)
• Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia
• Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation
• Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia
• Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
• Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy
• Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
• Biosynthesis of PGD2 in Vivo
• Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
• Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
• Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
• Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
• A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)
• Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia
• Effects of Hypolipemic Treatment on Adipokines
• A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin
• Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
• Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
• A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)
• Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
• Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
• Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia
• Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels
• Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
• Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus
• Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
• Treatment of Hyperlipidemia and Sexual Dysfunction
• Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
• Red Yeast Rice and Phytosterols In Statin Intolerance
• Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy
• Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)
• Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
• Zoladex Plus Tamoxifen in Breast Cancer
• Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
• Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
• Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia
• The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
• A Study to Evaluate the Lipid Regulating Effects of TRIA-662
• Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
• Ezetrol Post-Marketing Study
• Efficacy and Safety of Geneferm Nattokinase
• Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
• Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
• The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL)
• Pitavastatin on Carotid Intima-media Thickness
• Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
• Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol
• Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes
• An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
• Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
• Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
• Safety of a Hypolipidemic Agent in Healthy Normal Volunteers
• Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia
• IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
• Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes
• Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)
• Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)
• A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol
• Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus
• Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
• Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
• Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
• A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
• A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)
• Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
• Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease
• Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
• Effect of MK0524A on Cholesterol Levels (0524A-048)
• The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome
• Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
• Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
• Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
• Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
• An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia
• Cholesterol and Pharmacogenetic Study
• Lipid Lowering in Patients With Statin Intolerance
• Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)
• Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)
• Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements
• Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
• Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
• Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
• hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)
• Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)
• The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
• Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
• Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
• A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome
• Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
• TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)
• MK0859 Dose-Ranging Study (0859-003)
• The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles
• Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
• Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
• Cholesterol-Lowering Effects of Policosanol
• To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
• Lipid Efficacy Study (0524B-022)(COMPLETED)
• Lipid Efficacy/Tolerability Study (0524A-020)
• A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).
• A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
• A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.
• Policosanol for the Treatment of Hypercholesterolemia
• Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
• Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
• Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia
• A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia
• Pravastatin for Hyperlipidaemia in HIV.
• Japanese Primary Prevention Project With Aspirin
• Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study
• The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
• Type III Dysbetalipoproteinemia
• Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)
• A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
• A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
• Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
• Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients
• Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
• The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.
• Endothelial Hyperpolarization in Humans
• Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
• Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics
• Stop Atherosclerosis in Native Diabetics Study
• Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
• Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
• Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
• A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol
• Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.
• Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.
• A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol
• A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides
• Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia
• Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
• A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
• Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)
• The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
• Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
• A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
• Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
• Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
• Antihyperlipidemic Effects of Oyster Mushrooms
• Differential Metabolism of Dietary Fatty Acids
• Stop Atherosclerosis in Native Diabetics Study
• Garlic in Hyperlipidemia Caused by HAART
• Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia
• Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
• A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications